INS and type 2 diabetes mellitus: Pharmacologic treatment modalities were not very different between the groups, but we found that MODY (+) patients tended to start insulin therapy at a younger age than the negative group-did; thus, their insulin duration time was longer than that of the negative group, although their insulin doses were lower than the T2DM group.